Jefferies Group LLC Novavax Inc Put Options Transaction History

Jefferies Group LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Sep 21, 2023	BUY	$69.73 - $142.9 $697,300 - $1.43 Million	10,000 Added 80.65%	22,400 $1.65 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $697,300 - $1.43 Million	10,000 Added 80.65%	22,400 $1.65 Million
Q4 2021 Sep 21, 2023	BUY	$134.56 - $217.97 $1.33 Million - $2.16 Million	9,900 Added 396.0%	12,400 $1.77 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1.33 Million - $2.16 Million	9,900 Added 396.0%	12,400 $1.77 Million
Q3 2021 Sep 21, 2023	SELL	$177.8 - $270.58 $1.16 Million - $1.76 Million	-6,500 Reduced 72.22%	2,500 $518,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $1.16 Million - $1.76 Million	-6,500 Reduced 72.22%	2,500 $518,000
Q1 2021 Sep 21, 2023	SELL	$112.98 - $319.93 $7.12 Million - $20.2 Million	-63,000 Reduced 87.5%	9,000 $1.63 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $7.12 Million - $20.2 Million	-63,000 Reduced 87.5%	9,000 $1.63 Million
Q4 2020 Sep 21, 2023	BUY	$78.74 - $139.5 $3.91 Million - $6.92 Million	49,600 Added 221.43%	72,000 $8.03 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $393,700 - $697,500	-5,000 Reduced 6.49%	72,000 $8.03 Million
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $20.1 Million - $45.2 Million	-253,000 Reduced 76.67%	77,000 $8.34 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $2.49 Million - $15 Million	180,000 Added 120.0%	330,000 $27.5 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $589,500 - $2.4 Million	150,000 New	150,000 $2.04 Million

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.